L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests

Journal of Pharmacology and Experimental Therapeutics

Volumn 283, Issue 3, 1997, Pages 1256-1263

  Bristow, Linda J ^a   Collinson, Neil ^a   Cook, Gina P ^a   Curtis, Neil ^a   Freedman, Stephen B ^a   Kulagowski, Janusz J ^a   Leeson, Paul D ^a   Patel, Smita ^a   Ragan, C Ian ^a   Ridgill, Mark ^a   Saywell, Kay L ^a   Tricklebank, Mark D ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 ([4 (4 CHLOROPHENYL)PIPERAZIN 1 YL]METHYL) 1H PYRROLO[2,3 B]PYRIDINE; 3 [[4 (4 CHLOROPHENYL) 1 PIPERAZINYL]METHYL] 1H PYRROLO[2,3 B]PYRIDINE; AMPHETAMINE; APOMORPHINE; CLOZAPINE; DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; DRUG VEHICLE; HALOPERIDOL; MESCALINE; NEUROLEPTIC AGENT; RACLOPRIDE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ACOUSTIC REFLEX; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVOIDANCE BEHAVIOR; CATALEPSY; CONTROLLED STUDY; DRUG SELECTIVITY; HEAD TWITCH; HYPERACTIVITY; INTRAVENOUS DRUG ADMINISTRATION; LOCOMOTION; MALE; MOTOR PERFORMANCE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PREPULSE INHIBITION; PRIORITY JOURNAL; PSYCHOSIS; RAT; RECEPTOR AFFINITY; RECEPTOR OCCUPANCY; STARTLE REFLEX; STEREOTYPY; SUBCUTANEOUS DRUG ADMINISTRATION;

AMPHETAMINE; ANIMALS; ANTIPSYCHOTIC AGENTS; APOMORPHINE; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; DOPAMINE ANTAGONISTS; MALE; MICE; MOTOR ACTIVITY; PYRIDINES; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4;

EID: 15644381992     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. BALDESSARINI, R. J. AND FRANKENBURG, F. R.: Clozapine: A novel antipsychotic agent. N. Engl. J. Med. 324: 746-754, 1991.
2. 1A receptor. Eur. J. Pharmacol. 204: 21-28, 1991.
3. BURKI, H. R., SAYERS, A. C., RUCH, W. AND ASPER, H.: Effects of clozapine and other dibenzoepines on central dopaminergic and cholinergic systems. Arzneim-Forsch. 27: 1561-1565, 1977.
4. 1c sites. Eur. J. Pharmacol. 191: 93-96, 1990.
5. COSTALL, B. AND NAYLOR, R. J.: Neuroleptic and non-neuroleptic catalepsy. Arzneim-Forsch. 23: 674-683, 1973.
6. DAVIS, M.: Apomorphine, d-amphetamine, strychnine and yohimbine do not alter prepulse inhibition of the acoustic startle reflex. Psychopharmacology 95: 151-156, 1988.
7. DELEAN, A., MUNSON, P. J. AND RODBARD, D.: Simultaneous analysis of families of sigmoidal curves: applications to bioassay and physiological dose response curves. Am. J. Physiol. 235: E97-E102, 1978.
8. FITTON, A. AND HEEL, R. C.: Clozapine: A review of its pharmacological properties and therapeutic use in schizophrenia. Drugs 40: 722-747, 1990.
9. 4 receptor antagonist. Soc. Neurosci. Abst. 21: 191.11, 1995.
10. KANE, J., HONIGFELD, G., SINGER, J. AND MELTZER, H.: Clozapine for the treatment of treatment-resistant schizophrenics: a double blind comparison with chlorpromazine. Arch. Gen. Psychiatry 45: 789-796, 1988.
11. 2A antagonist with a favorable CNS safety profile. J. Pharmacol. Exp. Ther. 277: 968-981, 1996.
12. KELLY, P. H., SEVIOUR, P. W. AND IVERSEN, S. D.: Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res. 94: 507-522, 1975.
13. 4 receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia. Arch. Gen. Psychiatry 54: 567-572, 1997.
14. 4 receptor. J. Med. Chem. 39: 1941-1942, 1996.
15. LARGENT, B. L., WILKSTROM, H., SNOWMAN, A. M. AND SNYDER, S. H.: Novel antipsychotic drugs share high affinity for a receptors. Eur. J. Pharmacol. 155: 345-347, 1988.
16. 4 receptor. Mol. Brain. Res. 29: 157-162, 1995.
17. 4 receptor selective antagonist. J. Pharmacol. Exp. Ther. 279: 1392-1403, 1996.
18. 4 receptor. J. Pharmacol. Exp. Ther. 283: 636-647, 1997.
19. 4 receptor antagonist. Br J. Pharmacol. 119: 30P, 1996.
20. PIJNENBURG, A. J. J., HONIG, W. M. M. AND VAN ROSSUM, J. M.: Inhibition of d-amphetamine-induced locomotor activity by injection of haloperidol into the nucleus accumbens of the rat. Psychopharmacologia (Berl.) 41: 87-95, 1975.
21. 4 receptors in the action and development of antipsychotic agents. Drugs 51: 7-11, 1996.
22. 4 receptors increased in schizophrenia? J. Neurochem. 63: 1576-1577, 1994.
23. 4 receptors in drug-treated schizophrenia. Eur J. Pharmacol. 281: R5-R6, 1995.
24. RICHELSON, E. AND NELSON, A.: Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro. Eur. J. Pharmacol. 103: 197-204, 1984.
25. ROBERTS, G. W.: Schizophrenia: a neuropathological perspective. Br. J. Psychiatry 158: 8-17, 1991.
26. 2A receptors in antipsychotic activity. Life Sci. 56: 2209-2222, 1995.
27. 1A agonists. J. Pharmacol. Exp. Ther. 273: 101-112, 1995.
28. 4. Neuropsychopharmacology 7: 261-284, 1992.
29. 4 receptors elevated in schizophrenia. Nature 365: 441-445, 1993.
30. 125I]epidepride. Eur. J. Pharmacol. 286: R3-R5, 1995.
31. 2 receptor antagonist: receptor-binding, electrophysiological and neuropharmacological profiles. J. Pharmacol. Exp. Ther. 263: 1167-1174, 1992.
32. 4 receptor with high affinity for the antipsychotic clozapine. Nature 350: 610-614, 1991.
33. ZHANG, M., OUAGAZZAL, A. M., SUN, B. C. AND CREESE, I.: Regulation of motor behaviour by dopamine receptor subtypes. In The Dopamine Receptors, ed. by K. A. Neve and R. L. Neve, pp. 425-455, Humana Press Inc., Totowa, NJ, 1996.